RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 205 participants.
Also called NCT03584464
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 205 participants
- Sponsor
- Registry
-
NCT03584464
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, France, Slovakia
- Registry status
- Completed
Technical summary
Registry record NCT03584464. Allocation not applicable; no masking; primary purpose other. Start 2018-05-14 (actual); primary completion 2020-11-04 (actual). Results posted on 2022-01-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct03584464- Content hash
927dd6add08991a5d55890a34d779c8806b1edb884ec20b122546ffacc7c4b59